The price of Merck & Co Inc (NYSE:MRK) shares last traded on Wall Street rose 2.00% to $101.16.
MRK stock price is now -5.25% away from the 50-day moving average and -15.85% away from the 200-day moving average. The market capitalization of the company currently stands at $254.16B.
, while ‘Bernstein’ rates the stock as ‘Mkt Perform’
In other news, Merck & Co., Inc., 10% Owner bought 21,397,205 shares of the company’s stock on Mar 11 ’24. The stock was bought for $492,135,715 at an average price of $23.00. Upon completion of the transaction, the 10% Owner now directly owns 1,000 shares in the company, valued at $0.1 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 14 ’24, EVP & CFO Litchfield Caroline sold 38,291 shares of the business’s stock. A total of $4,805,520 was realized by selling the stock at an average price of $125.50. This leaves the insider owning 50,908 shares of the company worth $5.15 million. A total of 0.10% of the company’s stock is owned by insiders.
During the past 12 months, Merck & Co Inc has had a low of $94.48 and a high of $134.63. As of last week, the company has a debt-to-equity ratio of 0.86, a current ratio of 1.36, and a quick ratio of 1.15. According to the stock market information, the enterprise value for the company is $279493935104, which is based on a 21.19 price-to-earnings ratio, a 0.76 price-to-earnings-growth ratio, and a beta of 0.40. The fifty day moving average price for MRK is $107.0986 and a two-hundred day moving average price translates $120.333 for the stock.
The latest earnings results from Merck & Co Inc (NYSE: MRK) was released for 2024-09-30. The net profit margin was 19.32% and return on equity was 28.33% for MRK. The company reported revenue of $16.66 billion for the quarter, compared to $15.96 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.35 percent.
